Redox environment of the cell as viewed through the redox state of the glutathione disulfide/glutathione couple

FQ Schafer, GR Buettner - Free radical biology and medicine, 2001 - Elsevier
Redox state is a term used widely in the research field of free radicals and oxidative stress.
Unfortunately, it is used as a general term referring to relative changes that are not well …

Toward a better understanding of the complexity of cancer drug resistance

MM Gottesman, O Lavi, MD Hall… - Annual review of …, 2016 - annualreviews.org
Resistance to anticancer drugs is a complex process that results from alterations in drug
targets; development of alternative pathways for growth activation; changes in cellular …

Say no to DMSO: dimethylsulfoxide inactivates cisplatin, carboplatin, and other platinum complexes

MD Hall, KA Telma, KE Chang, TD Lee, JP Madigan… - Cancer research, 2014 - AACR
The platinum drugs cisplatin, carboplatin, and oxaliplatin are highly utilized in the clinic and
as a consequence are extensively studied in the laboratory setting. In this study, we …

Cisplatin-induced nephrotoxicity and targets of nephroprotection: an update

NAG dos Santos, MA Carvalho Rodrigues… - Archives of …, 2012 - Springer
Cisplatin is a highly effective antitumor agent whose clinical application is limited by the
inherent nephrotoxicity. The current measures of nephroprotection used in patients receiving …

Is cisplatin-induced cell death always produced by apoptosis?

VM Gonzalez, MA Fuertes, C Alonso, JM Perez - Molecular pharmacology, 2001 - ASPET
The platinum drugs represent a unique and important class of antitumor agents. The clinical
development of the neutral, square planar, coordination complex cis …

[HTML][HTML] Cisplatin nephrotoxicity: molecular mechanisms

MH Hanigan, P Devarajan - Cancer therapy, 2003 - ncbi.nlm.nih.gov
Cisplatin is one of the most widely used chemotherapeutic agents for the treatment of
several human malignancies. The efficacy of cisplatin is dose dependent, but the significant …

Aminoglycoside-and cisplatin-induced ototoxicity: mechanisms and otoprotective strategies

CJ Kros, PS Steyger - Cold Spring …, 2019 - perspectivesinmedicine.cshlp.org
Ototoxicity refers to damage of inner ear structures (ie, the cochlea and vestibule) and their
function (hearing and balance) following exposure to specific in-hospital medications (ie …

Recent developments in the field of tumor-inhibiting metal complexes

MS Galanski, VB Arion, MA Jakupec… - Current …, 2003 - ingentaconnect.com
25 years after the first approval of cisplatin in the clinic against a number of cancer diseases,
cisplatin and related compounds continue to be among the most efficient anticancer drugs …

Tumour-inhibiting platinum complexes—state of the art and future perspectives

MA Jakupec, MS Galanski, BK Keppler - Reviews of physiology …, 2003 - Springer
Thirty years after the onset of the first clinical studies with cisplatin, the development of
antineoplastic platinum drugs continues to be a productive field of research. This article …

Heteroleptic Pd (II) and Pt (II) Complexes with Redox-Active Ligands: Synthesis, Structure, and Multimodal Anticancer Mechanism

NF Romashev, PA Abramov, IV Bakaev… - Inorganic …, 2022 - ACS Publications
A series of heteroleptic square-planar Pt and Pd complexes with bis (diisopropylphenyl)
iminoacenaphtene (dpp-Bian) and Cl, 1, 3-dithia-2-thione-4, 5-dithiolate (dmit), or 1, 3-dithia …